Thijs Roelofsen

511 total citations
12 papers, 370 citations indexed

About

Thijs Roelofsen is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Thijs Roelofsen has authored 12 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 7 papers in Obstetrics and Gynecology and 3 papers in Immunology. Recurrent topics in Thijs Roelofsen's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Uterine Myomas and Treatments (2 papers). Thijs Roelofsen is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Uterine Myomas and Treatments (2 papers). Thijs Roelofsen collaborates with scholars based in Netherlands, Switzerland and Austria. Thijs Roelofsen's co-authors include Leon F.A.G. Massuger, Johan Bulten, Arie B. Brinkman, Sebastiaan W. C. Pennings, Joost H.A. Martens, Thomas Jenuwein, Hendrik G. Stunnenberg, Maaike A. van der Aa, Martijn H. den Brok and Jori A. Wagenaars and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Obstetrics and Gynecology.

In The Last Decade

Thijs Roelofsen

12 papers receiving 368 citations

Peers

Thijs Roelofsen
Thijs Roelofsen
Citations per year, relative to Thijs Roelofsen Thijs Roelofsen (= 1×) peers Kuan‐Chong Chao

Countries citing papers authored by Thijs Roelofsen

Since Specialization
Citations

This map shows the geographic impact of Thijs Roelofsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thijs Roelofsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thijs Roelofsen more than expected).

Fields of papers citing papers by Thijs Roelofsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thijs Roelofsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thijs Roelofsen. The network helps show where Thijs Roelofsen may publish in the future.

Co-authorship network of co-authors of Thijs Roelofsen

This figure shows the co-authorship network connecting the top 25 collaborators of Thijs Roelofsen. A scholar is included among the top collaborators of Thijs Roelofsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thijs Roelofsen. Thijs Roelofsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vledder, Annegé, Sterre T. Paijens, Evelien W. Duiker, et al.. (2024). B cells critical for outcome in high grade serous ovarian carcinoma. International Journal of Cancer. 155(12). 2265–2276. 1 indexed citations
2.
Roelofsen, Thijs, Mark A.J. Gorris, Johannes Textor, et al.. (2018). Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report. Frontiers in Oncology. 8. 562–562. 12 indexed citations
3.
Roelofsen, Thijs, Yvette P. Geels, Johanna M.A. Pijnenborg, et al.. (2013). Cervical Cytology in Serous and Endometrioid Endometrial Cancer. International Journal of Gynecological Pathology. 32(4). 390–398. 10 indexed citations
4.
Roelofsen, Thijs, et al.. (2012). Concurrent Endometrial Intraepithelial Carcinoma (EIC) and Serous Ovarian Cancer. International Journal of Gynecological Cancer. 22(3). 457–464. 22 indexed citations
5.
Roelofsen, Thijs, et al.. (2012). Pure Compared With Mixed Serous Endometrial Carcinoma. Obstetrics and Gynecology. 120(6). 1371–1381. 20 indexed citations
6.
Roelofsen, Thijs, Jeroen van der Laak, Joanne A. de Hullu, et al.. (2012). Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. Gynecologic Oncology. 127(1). 88–93. 50 indexed citations
7.
Roelofsen, Thijs, Jan C.M. Hendriks, Rahul A.�K. Samlal, et al.. (2012). Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients. The International Journal of Biological Markers. 27(3). 263–271. 14 indexed citations
8.
Roelofsen, Thijs, et al.. (2010). Clinical management of uterine papillary serous carcinoma. Expert Review of Anticancer Therapy. 11(1). 71–81. 16 indexed citations
9.
Massuger, Leon F.A.G., et al.. (2009). The origin of serous ovarian cancer may be found in the uterus: A novel hypothesis. Medical Hypotheses. 74(5). 859–861. 29 indexed citations
10.
Nierkens, Stefan, Martijn H. den Brok, Thijs Roelofsen, et al.. (2009). Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice. PLoS ONE. 4(12). e8368–e8368. 79 indexed citations
11.
Roelofsen, Thijs, et al.. (2008). Sphingosine‐1‐phosphate acts as a developmental stage specific inhibitor of platelet‐derived growth factor‐induced chemotaxis of osteoblasts. Journal of Cellular Biochemistry. 105(4). 1128–1138. 34 indexed citations
12.
Brinkman, Arie B., Thijs Roelofsen, Sebastiaan W. C. Pennings, et al.. (2006). Histone modification patterns associated with the human X chromosome. EMBO Reports. 7(6). 628–634. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026